litlas
Log inCreate account

Samuel I. Miller

Active 1980–2024

157
Papers
36,288
Citations
109
h-index
155
i10-index

Citations

Citations per year for Samuel I. Miller1982: 1 citations1983: 1 citations1985: 2 citations1986: 3 citations1987: 16 citations1988: 10 citations1989: 10 citations1990: 13 citations1991: 18 citations1992: 42 citations1993: 54 citations1994: 67 citations1995: 101 citations1996: 136 citations1997: 131 citations1998: 197 citations1999: 259 citations2000: 339 citations2001: 384 citations2002: 326 citations2003: 360 citations2004: 430 citations2005: 461 citations2006: 534 citations2007: 488 citations2008: 437 citations2009: 489 citations2010: 472 citations2011: 519 citations2012: 421 citations2013: 455 citations2014: 431 citations2015: 388 citations2016: 413 citations2017: 314 citations2018: 244 citations2019: 1,006 citations2020: 973 citations2021: 896 citations2022: 716 citations2023: 462 citations2024: 629 citations2025: 295 citations2026: 7 citations1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,129 citing papers, 32.9% of this breakdownChina: 961 citing papers, 7.7% of this breakdownUnited Kingdom: 891 citing papers, 7.1% of this breakdownGermany: 740 citing papers, 5.9% of this breakdownCanada: 620 citing papers, 4.9% of this breakdownFrance: 547 citing papers, 4.4% of this breakdownAustralia: 340 citing papers, 2.7% of this breakdownSwitzerland: 327 citing papers, 2.6% of this breakdownSpain: 286 citing papers, 2.3% of this breakdownJapan: 284 citing papers, 2.3% of this breakdownItaly: 250 citing papers, 2% of this breakdownIndia: 228 citing papers, 1.8% of this breakdown
0%32.9%Other 23.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology49.8%
  • Medicine15.1%
  • Immunology and Microbiology13.8%
  • Agricultural and Biological Sciences11.9%
  • Environmental Science3.2%
  • Chemistry2%
  • Other4.2%

Topics

  • Bacterial biofilms and quorum sensing6.1%
  • Antibiotic Resistance in Bacteria5.6%
  • Bacterial Genetics and Biotechnology5.3%
  • Vibrio bacteria research studies4.9%
  • Salmonella and Campylobacter epidemiology4.3%
  • Bacteriophages and microbial interactions3.3%
  • Other70.5%

Coauthors

All papers

Open in search
  1. LPS, TLR4 and infectious disease diversity

    Authors: Samuel I. Miller, Robert K. Ernst, Martin W. Bader - Nature Reviews Microbiology 2004 cited by 981

  2. Aminoglycoside antibiotics induce bacterial biofilm formation

    Authors: Lucas R. Hoffman, David A. D’Argenio, Michael J. MacCoss, Zhaoying Zhang, Roger A. Jones, Samuel I. Miller - Nature 2005 cited by 1,318

  3. Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues

    Authors: Zijie Feng, Xin He, Xuyao Zhang, Yuan Wu, Bowen Xing, Alison Knowles, Qiaonan Shan, Samuel I. Miller, Taylor Hojnacki, Jian Ma, Bryson W. Katona, T. Gade, Don L. Siegel, Jörg Schrader, David C. Metz, Carl H. June, Xianxin Hua - Nature Cancer 2022 cited by 97

  4. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo

    Authors: K. Brooks Low, Martina Ittensohn, Trung Bao Le, James T. Platt, Stefano Sodi, Max S. Amoss, Olivia Ash, Ellen P. Carmichael, Ashok K. Chakraborty, Jessica Fischer, Stanley L. Lin, Xiang Luo, Samuel I. Miller, Li-Mou Zheng, Ivan King, John M. Pawelek, David Bermudes - Nature Biotechnology 1999 cited by 476

  5. Salmonellae interactions with host processes

    Authors: Doris L. LaRock, Anu Chaudhary, Samuel I. Miller - Nature Reviews Microbiology 2015 cited by 496

  6. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf

    Authors: Edward A. Miao, Celia Alpuche‐Aranda, Monica Dors, April Clark, Martin W. Bader, Samuel I. Miller, Alan Aderem - Nature Immunology 2006 cited by 1,124

  7. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients

    Authors: Eric E. Smith, Danielle Buckley, Zaining Wu, Channakhone Saenphimmachak, Lucas R. Hoffman, David A. D’Argenio, Samuel I. Miller, Bonnie W. Ramsey, David P. Speert, Samuel M. Moskowitz, Jane L. Burns, Rajinder Kaul, Maynard V. Olson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 1,351

  8. Salmonellae interplay with host cells

    Authors: Andrea Haraga, Maikke B. Ohlson, Samuel I. Miller - Nature Reviews Microbiology 2007 cited by 833

  9. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis

    Authors: Ohad Manor, Roie Levy, Christopher E. Pope, Hillary S. Hayden, M. Brittnacher, Rogan Carr, Matthew C. Radey, Kyle R. Hager, Sonya L. Heltshe, Bonnie W. Ramsey, Samuel I. Miller, Lucas R. Hoffman, Elhanan Borenstein - Scientific Reports 2016 cited by 140

  10. PmrAB, a Two-Component Regulatory System of Pseudomonas aeruginosa That Modulates Resistance to Cationic Antimicrobial Peptides and Addition of Aminoarabinose to Lipid A

    Authors: Samuel M. Moskowitz, Robert K. Ernst, Samuel I. Miller - Journal of Bacteriology 2003 cited by 414

  11. Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis

    Authors: Laurence Rohmer, Didier Hocquet, Samuel I. Miller - Trends in Microbiology 2011 cited by 377

  12. Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome Profiles

    Authors: Maria T. Nelson, Christopher E. Pope, Robyn L. Marsh, Daniel J. Wolter, Eli J. Weiss, Kyle R. Hager, Anh T. Vo, M. Brittnacher, Matthew C. Radey, Hillary S. Hayden, Alexander Eng, Samuel I. Miller, Elhanan Borenstein, Lucas R. Hoffman - Cell Reports 2019 cited by 180

  13. Antibiotic Resistance and Regulation of the Gram-Negative Bacterial Outer Membrane Barrier by Host Innate Immune Molecules

    Authors: Samuel I. Miller - mBio 2016 cited by 251

  14. PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients

    Authors: Amanda Miller, Mark K. Brannon, Laurel Stevens, Helle Krogh Johansen, Sara E. Selgrade, Samuel I. Miller, Niels Høiby, Samuel M. Moskowitz - Antimicrobial Agents and Chemotherapy 2011 cited by 224

  15. Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides

    Authors: Lin Guo, Kheng B. Lim, Cristina M Poduje, Morad Daniel, John S. Gunn, Murray Hackett, Samuel I. Miller - Cell 1998 cited by 663

  16. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa

    Authors: Lucas R. Hoffman, Éric Déziel, David A. D’Argenio, François Lépine, Julia Emerson, Sharon McNamara, Ronald L. Gibson, Bonnie W. Ramsey, Samuel I. Miller - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 474

  17. Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohnʼs Disease

    Authors: David L. Suskind, M. Brittnacher, Ghassan Wahbeh, Michele L. Shaffer, Hillary S. Hayden, Xuan Qin, Namita Singh, Christopher J. Damman, Kyle R. Hager, Heather Nielson, Samuel I. Miller - Inflammatory Bowel Diseases 2015 cited by 244

  18. Inhibiting the Evolution of Antibiotic Resistance

    Authors: Mark N. Ragheb, Maureen K. Thomason, Chris Hsu, Patrick Nugent, John Gage, Ariana N. Samadpour, Ankunda Kariisa, Christopher N. Merrikh, Samuel I. Miller, David R. Sherman, Houra Merrikh - Molecular Cell 2018 cited by 206

  19. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure

    Authors: Hillary S. Hayden, Alexander Eng, Christopher E. Pope, M. Brittnacher, Anh T. Vo, Eli J. Weiss, Kyle R. Hager, Bryan D Martin, Daniel H. Leung, Sonya L. Heltshe, Elhanan Borenstein, Samuel I. Miller, Lucas R. Hoffman - Nature Medicine 2020 cited by 108

  20. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression

    Authors: Lucas R. Hoffman, Hemantha D. Kulasekara, Julia Emerson, Laura S. Houston, Jane L. Burns, Bonnie W. Ramsey, Samuel I. Miller - Journal of Cystic Fibrosis 2008 cited by 320

  21. Precursor Acquisition Independent From Ion Count: How to Dive Deeper into the Proteomics Ocean

    Authors: Alexandre Panchaud, Alexander Scherl, Scott A. Shaffer, Priska D. von Haller, Hemantha D. Kulasekara, Samuel I. Miller, David R. Goodlett - Analytical Chemistry 2009 cited by 271

  22. Escherichia coli Dysbiosis Correlates With Gastrointestinal Dysfunction in Children With Cystic Fibrosis

    Authors: Lucas R. Hoffman, Christopher E. Pope, Hillary S. Hayden, Sonya L. Heltshe, Roie Levy, Sharon McNamara, Michael A. Jacobs, Laurence Rohmer, Matthew C. Radey, Bonnie W. Ramsey, M. Brittnacher, Elhanan Borenstein, Samuel I. Miller - Clinical Infectious Diseases 2013 cited by 114

  23. CFTR dysregulation drives active selection of the gut microbiome

    Authors: Stacey Meeker, Kevin S Mears, Naseer Sangwan, M. Brittnacher, Eli J. Weiss, Piper M. Treuting, Nicholas Tolley, Christopher E. Pope, Kyle R. Hager, Anh T. Vo, Jisun Paik, Charles W. Frevert, Hillary S. Hayden, Lucas R. Hoffman, Samuel I. Miller, Adeline M. Hajjar - PLoS Pathogens 2020 cited by 80

  24. PmrA–PmrB‐regulated genes necessary for 4‐aminoarabinose lipid A modification and polymyxin resistance

    Authors: John S. Gunn, Kheng B. Lim, Jackie Krueger, Kevin Kim, Lin Guo, Murray Hackett, Samuel I. Miller - Molecular Microbiology 1998 cited by 661